All terms in NCIT
| Label | Id | Description |
|---|---|---|
| MAGE-3 Peptide (9-mer) | NCIT_C29188 | [A peptide derived from MAGE-3, a tumor-associated protein expressed by a variety of cancer cell types, including melanoma, breast, colon, lung, and thyroid. Dendritic cells harvested from a cancer patient may be exposed to or pulsed with the 9-mer MAGE-3 peptide (FLWGPRALV). Autologous vaccination with these altered dendritic cells may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for MAGE-3, resulting in decreased tumor growth. (NCI04)] |
| Jojoba Oil | NCIT_C107318 | [The oil extracted from the seeds of Simmondsia chinensis. Jojoba oil is used primarily in cosmetics.] |
| Mixture of Germ Cell Neoplastic Components Present | NCIT_C54145 | |
| Mixture of Morphologic Patterns | NCIT_C54241 | |
| Kanuka Oil | NCIT_C107319 | [The essential oil of Leptospermum (Kunzea) ericoides. Kanuka oil has anti-fungal and anti-inflammatory properties and is used in skincare preparations.] |
| Childhood Myelodysplastic Syndrome | NCIT_C68744 | [An uncommon hematologic malignancy occurring during childhood. Many of the morphologic, immunophenotypic, and genetic changes seen in adult myelodysplastic syndromes are also observed in the childhood variants of the disease. Children present with neutropenia and thrombocytopenia more often than adults, and bone marrow hypocellularity is more often seen in children than adults.] |
| Childhood Hematopoietic Neoplasm | NCIT_C9431 | |
| Unit of Electric Charge | NCIT_C68747 | |
| HER2/Neu Positive | NCIT_C68748 | [A laboratory test result indicating the presence of HER2/Neu in a tissue sample.] |
| HER2/Neu Status | NCIT_C16152 | [The presence or absence of Her2/Neu on a tissue sample.] |
| HER2/Neu Negative | NCIT_C68749 | [The absence of detectable HER2/Neu in a tissue sample.] |
| HER2/Neu Status Unknown | NCIT_C68750 | [The result of the HER2/Neu test is not known or the test has not been performed.] |
| Smoker | NCIT_C68751 | [A person who inhales or has inhaled combustible products of organic material during their lifetime.] |
| Smoking Status | NCIT_C19796 | [An indication of a person's current tobacco and nicotine consumption as well as some indication of smoking history.] |
| Palisading Necrosis | NCIT_C68752 | [A morphologic appearance consisting of small, irregular regions of necrosis surrounded by dense accumulations of tumor cells; the tumor cells are more densely packed at the edge of the necrosis than in other regions of the tumor and thus appear to "palisade" around the necrotic zone.] |
| Genomic Biomarker | NCIT_C68753 | [A measurable DNA or RNA characteristic that is an indicator of normal biologic processes, pathogenic processes, and/or response to therapeutic or other intervention. The definition for a genomic biomarker is not limited to human samples. A genomic biomarker could, for example, reflect: the expression of a gene; the function of a gene; the regulation of a gene. A genomic biomarker can consist of one or more deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) characteristics. The definition for a genomic biomarker does not include the measurement and characterisation of proteins or low molecular weight metabolites. DNA characteristics include, but are not limited to: single nucleotide polymorphisms (SNPs); variability of short sequence repeats; DNA modification, e.g., methylation; insertions; deletions; copy number variation; cytogenetic rearrangements, e.g., translocations, duplications, deletions or inversions. RNA characteristics include, but are not limited to: RNA sequence; RNA expression levels; RNA processing, e.g., splicing and editing; microRNA levels (ICH Draft Consensus Guideline E15).] |
| Biomarker | NCIT_C16342 | [A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.] |
| Limited Company | NCIT_C54135 | [A business structure used in Europe and Canada, in which shareholder responsibility for company debt is limited to the amount he/she has invested in the company.] |
| Limited Liability Partnership | NCIT_C54136 | [A type of company, authorized only in certain states, whose owners and managers receive the limited liability and (usually) tax benefits of an S Corporation without having to conform to the S corporation restrictions.] |
| Limited Partnership | NCIT_C54137 | [A business organization with one or more general partners, who manage the business and assume legal debts and obligations, and one or more limited partners, who are liable only to the extent of their investments. Limited partners also enjoy rights to the partnership's cash flow, but are not liable for company obligations.] |